NorthWest Biotherapeutics Inc (NWBO)

[Doktornolittle]

I can't find the report that I am recalling. What I thought I read recently was that Agenus did report Phase 2 results for Prophage and plans for phase 3. What I thought I read was that results were good, but only for the patients that respond to Temador, which was about half the patients, so their plan was to utilize a blockade inhibitor with the other half of patients.

I will keep looking for the report.

Whatever that report was, it appeared to tank DMPI, and I assumed the reason was that "DMPI's" chemo was not chosen for the Temador non-responders.